Aug 142017
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Xenetic Biosciences, Inc. (NASDAQ:XBIO), a clinical-stage biopharmaceutical company focused on the discovery, research and development of next-generation biologic drugs and novel orphan oncology therapeutics, announced today that it has appointed Adam Logal, James E.=> Read more

Xenetic Biosciences appoints Adam Logal, James Callaway and Dmitry Genkin to the Board of Directors

From:: Xenetic Biosciences appoints Adam Logal, James Callaway and Dmitry Genkin to the Board of Directors

Sorry, the comment form is closed at this time.

%d bloggers like this: